Telomerase as a therapeutic target in glioblastoma.

Abstract excerpt

Glioblastoma is the most common primary malignant brain tumor in adults and it continues to have a dismal prognosis. The development of targeted therapeutics has been particularly challenging, in part due to a limited number of oncogenic mutations and significant intra-tumoral heterogeneity. TERT promoter mutations were first discovered in melanoma and later found to be present in up to 80% of glioblastoma...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Telomeres, Telomerase, and Senescence
• Share to Advanced biosensing and bioanalysis techniques